Home ›
About ›
Communications ›
NCBA News ›
2007 News Articles › Mediator Is Newest NCBA Member Benefit
Mediator Is Newest NCBA Member Benefit
Article Date: Friday, November 16, 2007
Written By: Russell Rawlings
North Carolina Bar Association Chooses Mediator™
By SyynX Solutions for Medical Discovery Research
New Research Tools Puts NCBA at the Forefront of Law and Technology
(Released by Avalanche Strategic Communications for Collexis Holdings, Inc.)
(Columbia, S.C., Nov. 6, 2007) – North Carolina Bar Association (NCBA) members will now be able to conduct medical discovery and research online as a member benefit using Mediator™, a web-based research tool powered by SyynX Solutions a wholly owned subsidiary of Collexis Holdings, Inc., a leading developer of high definition search and discovery software (OTCBB:CLXS).
Mediator™ provides access to the most relevant information for biomedical, pharmaceutical, drug, medical devices, medical malpractice and personal injury research. It enables users to search the full text of five million global biomedical abstracts available through the National Library of Medicine abstract system as well as and identify the most relevant medical research information and associated global experts.
The proprietary Mediator™ technology platform is already in use by global health organizations such as Johns Hopkins, the Mayo Clinic, Harvard University’s Dana Farber Cancer Institute and The National Institutes of Health to identify leading researchers in a wide arrange of disciplines. This technology has now been expanded to provide legal professionals with the ability to identify, quantify and qualify expert witnesses in all areas of biomedical and healthcare litigation.
"I am very enthusiastic about our new venture with the North Carolina Bar Association and the introduction of Mediator™,” said Bill Kirkland, CEO of Collexis Holdings Inc.” Mediator™ will help North Carolina lawyers search over one million biomedical profiles to identify experts and assist with case preparation.”
“The NCBA is proud to present yet another member benefit that puts technology to work to improve the efficiency and effectiveness of the practice of law in North Carolina,” said NCBA Executive Director Allan Head. “The Association’s Strategic Planning/Emerging Trends Committee has identified correctly that one of the most valuable services the NCBA can provide its members in the future is to manage the overload of information.
“The Collexis partnership arrangement is a wonderful example of the power of association – doing things together that we could not have done by ourselves. My expectation is that this is the first of many such research and discovery tools that will aid North Carolina lawyers for years to come.”
Through comparative analysis utilizing Collexis's Fingerprinting technology, documents are compared for degrees of relevancy and key ideas are immediately identified. Once the results are identified, so are the experts publishing in that field. Mediator™ then provides a complete histogram of the expert's knowledge based on all of his/her publications.
Mediator™ can also help evaluate an opposition's expert opinion. The search engine can Fingerprint the concepts underlying the opposing expert's report and identify other related documents. These findings may suggest issues and questions not previously considered relevant. In addition, deposition testimony can be similarly analyzed to identify pertinent articles as they relate to that particular testimony.
About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of High Definition Search and Discovery software since 1999, is headquartered in Columbia, South Carolina (USA) with operations in Geldermalsen, The Netherlands and, with the acquisition of SyynX Solutions, in Cologne, Germany. Collexis’ proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, websites, e-mails and other digitized content and matches them with a comprehensive list of pre-defined “fingerprinted” concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as “finding needles in many haystacks.”
Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. The proprietary Collexis Fingerprint technology, is already a valuable research tool employed globally by organizations such as Johns Hopkins, the Mayo Clinic, Harvard University’s Dana Farber Cancer Institute and The National Institutes of Health. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, please visit www.collexis.com.
About The North Carolina Bar Association
A voluntary organization more than 13,500 members strong, The North Carolina Bar Association is the largest organization in the state serving the diverse professional needs of lawyer, including providing both attorneys and the general public with professional support, lobbying on issues of interest to the Bar, continuing legal education programs, legal information materials, the Lawyer Referral Service, and support for pro bono legal services. The NCBA, which annually counts more than 70 percent of the state's practicing attorneys among its membership, is the largest voluntary legal organization in North Carolina. For more information, please visit: /{localLink:1418}.
Forward-Looking Statements
Some of the statements made in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations and include known and unknown risks, uncertainties and other factors, many of which the company is unable to predict or control, that may cause the company’s actual results or performance to differ materially from any future results or performance expressed or implied by such forward-looking statements. These statements involve risks and uncertainties, including risks and uncertainties associated with the acquisition of SyynX, with whether the benefits of the acquisition will occur as anticipated, and with the planned launch of the company’s social networking and collaboration platform for the biomedical research community. These risks and uncertainties are in addition to other factors detailed from time to time in the company’s filings with the SEC, including the section entitled “Risk Factors” in its transition report on Form 10-KSB for the period ended June 30, 2007. The company cautions investors that any forward-looking statements made by the company are not necessarily indicative of future performance. The company is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.
Contact information
Allan L. Crawford
Collexis, Inc
Tel. + 1-803-727-1113
Tel. + 1-803-622-8718 mobile
crawford@collexis.com